Cargando…

Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies

There is a renewed interest in delivering pharmaceutical products via intravaginal rings (IVRs). IVRs are flexible torus-shaped drug delivery systems that can be easily inserted and removed by the woman and that provide both sustained and controlled drug release, lasting for several weeks to several...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thurman, Andrea Ries, Clark, Meredith R, Hurlburt, Jennifer A, Doncel, Gustavo F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808127/ https://www.ncbi.nlm.nih.gov/pubmed/24174884 http://dx.doi.org/10.2147/IJWH.S34030

Ejemplares similares

Multipurpose Prevention Technologies: Biomedical Tools to Prevent HIV-1, HSV-2, and Unintended Pregnancies
por: Thurman, Andrea Ries, et al.
Publicado: (2011)

Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies
por: Jacot, Terry A., et al.
Publicado: (2018)

Preferred product attributes of a multipurpose vaginal ring: Findings from a phase 1 trial
por: Tolley, Elizabeth E., et al.
Publicado: (2023)

Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model
por: Smith, James M., et al.
Publicado: (2017)

Multipurpose Prevention Approaches with Antiretroviral-Based Formulations
por: Jean-Pierre, Ninochka, et al.
Publicado: (2016)

Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic
por: Tolley, Elizabeth E., et al.
Publicado: (2022)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Development of Hormonal Intravaginal Rings: Technology and Challenges
por: Rafiei, Fojan, et al.
Publicado: (2021)

Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration
por: Ouattara, Louise A., et al.
Publicado: (2022)

The Implications of Post-coital Intravaginal Cleansing for the Introduction of Vaginal Microbicides in South Africa
por: Gafos, Mitzy, et al.
Publicado: (2013)

A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo
por: Villegas, Guillermo, et al.
Publicado: (2016)

Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting
por: Vallely, Andrew, et al.
Publicado: (2012)

Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine
por: Chen, Yufei, et al.
Publicado: (2014)

Topical Inserts: A Versatile Delivery Form for HIV Prevention
por: Peet, M. Melissa, et al.
Publicado: (2019)

Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use
por: Gafos, Mitzy, et al.
Publicado: (2010)

The Formulated Microbicide RC-101 Was Safe and Antivirally Active Following Intravaginal Application in Pigtailed Macaques
por: Cole, Alexander M., et al.
Publicado: (2010)

End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa
por: Brown, Morgan S., et al.
Publicado: (2022)

Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy
por: Clark, Justin T., et al.
Publicado: (2014)

Microbicides 2008 conference: From discovery to advocacy
por: Ramjee, Gita, et al.
Publicado: (2008)

Development and in vitro/in vivo Evaluation of a Silastic Intravaginal Ring for Mifepristone Delivery
por: Duan, X., et al.
Publicado: (2015)

Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya
por: Dabee, Smritee, et al.
Publicado: (2022)

3466 Innovative 3D Printed Intravaginal Rings: Developing AnelleO PRO, the First Intravaginal Ring for Infertility
por: Janusziewicz, Rima, et al.
Publicado: (2019)

Intravaginal and Menstrual Practices among Women Working in Food and Recreational Facilities in Mwanza, Tanzania: Implications for Microbicide Trials
por: Allen, Caroline F., et al.
Publicado: (2010)

Preparation and Evaluation of Intravaginal Ring Containing Drospirenone
por: Zhang, Ying, et al.
Publicado: (2013)

Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237
por: Tayyar, Yaman, et al.
Publicado: (2019)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

2153: Innovative 3D printed intravaginal rings for contraception and HIV prevention
por: Benhabbour, Rahima, et al.
Publicado: (2018)

Preclinical evaluation of lime juice as a topical microbicide candidate
por: Fletcher, Patricia S, et al.
Publicado: (2008)

Absence of Effect of Intravaginal Miconazole, Clindamycin, Nonoxynol‐9, and Tampons on the Pharmacokinetics of an Anastrozole/Levonorgestrel Intravaginal Ring
por: Nave, Rüdiger, et al.
Publicado: (2017)

The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development
por: Morrow Guthrie, Kate, et al.
Publicado: (2015)

Engineering monoclonal antibody-based contraception and multipurpose prevention technologies(†)
por: Anderson, Deborah J, et al.
Publicado: (2020)

An intravaginal ring for real-time evaluation of adherence to therapy
por: Moss, John A., et al.
Publicado: (2017)

Microbicides for HIV prevention
por: Ramjee, Gita
Publicado: (2011)

Turning the promise of multipurpose prevention technologies into a market reality: a commentary
por: Dam, Anita, et al.
Publicado: (2023)

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring
por: Thurman, Andrea R., et al.
Publicado: (2022)

Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya
por: Mugo, Nelly R., et al.
Publicado: (2023)

Commentary: Multipurpose prevention technologies—What about sexually transmitted infections?
por: Lu, Anjanique Mariquit Rosete, et al.
Publicado: (2023)

Novel Vaginal Microflora Colonization Model Providing New Insight into Microbicide Mechanism of Action
por: Fichorova, Raina N., et al.
Publicado: (2011)

Cost-effective automated multipurpose delivery system software for hospitals
por: Hrisafov, Mag. Kocho, et al.
Publicado: (2022)

Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
por: Ravel, Jacques, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cirbhhb497cviioh0nbg3v1jv2